Champions Oncology, Inc. (CSBR)
Champions Oncology, Inc.
One University Plaza
Suite 307
Hackensack, NJ 07601
United States
201 808 8400
https://www.championsoncology.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 230
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Ronnie Morris M.D. | CEO & Director | 600k | N/D | 1966 |
| Mr. David Barry Miller M.B.A. | Chief Financial Officer | 285k | N/D | 1969 |
| Mr. Brady Davis | President | N/D | N/D | N/D |
| Dr. Maria Mancini Ph.D. | Chief Operating Officer | N/D | N/D | N/D |
| Mr. Arthur Hanson | Vice President of Technology | N/D | N/D | N/D |
| Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS | VP of Global Marketing | N/D | N/D | N/D |
| Mr. David DeOrnellis BS, CMAR, CPIA, RLATG | Executive Vice President of Global Laboratory Operations | N/D | N/D | N/D |
| Dr. Michael Ritchie M.B.A., Ph.D. | Chief Commercial Officer | N/D | N/D | N/D |
| Dr. Karin Abarca Heidemann Ph.D. | Executive Vice President of Global Scientific Operations | N/D | N/D | N/D |
| Dr. Marianna Zipeto Ph.D. | Executive Vice President of Commercial, Research Services & Partnering | N/D | N/D | N/D |
Descripción
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Gestión corporativa
La calificación ISS Governance QuickScore de Champions Oncology, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
